AJGP Logo
AJGP Logo
  • Article type
    Beyond the clinic door Book review Case Study Clinical Clinical challenge Column Editorial Letters Professional Research Viewpoint
  • Current issue
  • Previous issues
    Academic Post Registrar abstract supplements
     
    WONCA 2023 abstracts
     
    Coronavirus
     
    April 2025 Obesity and weight management March 2025 Psychological medicine January–February 2025 Disaster management December 2024 General practice training and education All issues
     
    Australian Family Physician (AFP)
  • Authors / Reviewers
    Author guidelinesPeer reviewer guidelinesRACGP Clinical guidelinesEditorial Advisory Committee Submit a manuscript
  • About the journal
  • Subscribe to AJGP
  Search
AJGP > Search


Impact of harm reduction practice on the use of non-prescribed performance and image-enhancing drugs: The PUSH! Audit

Impact of harm reduction practice on the use of non-prescribed performance and image-enhancing drugs: The PUSH! Audit

29/03/2023

We describe the different performance- and image enhancing drugs (PIEDs) in Australia. This study examined the impact of harm reduction practice in the PIEDs UserS’ Health (PUSH!) Audit.


Engaging patients who use alcohol and other drugs: A practical approach

Engaging patients who use alcohol and other drugs: A practical approach

18/02/2023

A clear and practical approach for general practitioners to support patients who use alcohol and drugs.


Deprescribing considerations for older people in general practice

Deprescribing considerations for older people in general practice

29/03/2023

This article collates the latest evidence on deprescribing to guide general practitioners (GPs) and nurse practitioners on how to deprescribe for their elderly patients.


How stigmatising language affects people in Australia who use tobacco, alcohol and other drugs

How stigmatising language affects people in Australia who use tobacco, alcohol and other drugs

20/02/2020

Stigma communicated through words can affect people seeking help and undertaking treatment for their health issues.


New frontiers in the management of dyslipidaemia: Proprotein convertase subtilisin/kexin 9 inhibitors and small interfering ribonucleic acid

New frontiers in the management of dyslipidaemia: Proprotein convertase subtilisin/kexin 9 inhibitors and small interfering ribonucleic acid

01/06/2023

This paper provides a summary of the evidence supporting the use of PCSK9 inhibitors and siRNA, with relevant recommendations from consensus guidelines.


Pharmacy prescribing and the impact on women

Pharmacy prescribing and the impact on women's healthcare

27/10/2023

This study discusses the potential adverse effects on women’s health of pharmacists diagnosing and treating urinary tract infections and other disease due to the shortage of general practitioners.


Nangs, balloons and crackers: Recreational nitrous oxide neurotoxicity

Nangs, balloons and crackers: Recreational nitrous oxide neurotoxicity

21/10/2021

A recent resurgence of nitrous oxide abuse among Australian youth has led to marked neurological morbidity.


The older patient presenting with itch and a recent medication change

The older patient presenting with itch and a recent medication change

26/04/2020

Two patients presented with a history of widespread itch with blisters (bullae).


Misconceptions regarding dairy intake around thyroxine administration in pregnant and postpartum women

Misconceptions regarding dairy intake around thyroxine administration in pregnant and postpartum women

01/06/2023

Hypothyroidism requiring T4 replacement is common in pregnancy. Prescribers should be aware that there are no specific concerns about dairy intake with T4.


Hepatitis C direct-acting antiviral treatment completion: Comparison of geographic, demographic and clinical characteristics in Australia

Hepatitis C direct-acting antiviral treatment completion: Comparison of geographic, demographic and clinical characteristics in Australia

01/06/2023

Hepatitis C virus treatment uptake varies by geographic area in Australia. This study investigated treatment completion according to remoteness, as well as demographic and clinical characteristics.


The assessment and management of gamma hydroxybutyrate use in general practice

The assessment and management of gamma hydroxybutyrate use in general practice

30/01/2020

Gamma hydroxybutyrate is associated with a disproportionate burden of harm despite low overall population prevalence of use.


Potential therapeutic uses of cannabinoids to treat behavioural problems in children and adolescents with developmental disorders

Potential therapeutic uses of cannabinoids to treat behavioural problems in children and adolescents with developmental disorders

26/05/2021

There is a great deal of interest in the potential symptomatic benefits of medicinal cannabis for developmental disorders.

  • Previous
  • 1
  • Next
Pages: 1 of 1

Australian Journal of General Practice (AJGP) is published by The Royal Australian College of General Practitioners, 100 Wellington Parade, East Melbourne, Victoria 3002, Australia

Email ajgp@racgp.org.au

RACGP Logo

The Royal Australian College of General Practitioners acknowledges Aboriginal and Torres Strait Islander peoples as the Traditional Custodians of the land and sea in which we live and work, we recognise their continuing connection to land, sea and culture and pay our respects to Elders past, present and future.

© 2024 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807